Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience

PURPOSE: In China, many patients with hepatocellular carcinoma (HCC) are diagnosed at an advanced stage. Several studies have shown that triple therapy [transarterial chemoembolization (TACE) combined with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs)] is beneficial for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xian, Wu, Shao-Jie, Tang, Yi, Zhou, Yan-Feng, Luo, Jie-Wei, Fang, Zhu-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263012/
https://www.ncbi.nlm.nih.gov/pubmed/37324411
http://dx.doi.org/10.2147/JHC.S404500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263012/
https://www.ncbi.nlm.nih.gov/pubmed/37324411
http://dx.doi.org/10.2147/JHC.S404500

Ejemplares similares